The Evolution of MASLD Management: From Revised Nomenclature to Disease-Modifying Therapies
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of global chronic liver disease, with a prevalence of approximately 30%. This review outlines the diagnostic transition from the exclusionary non-alcoholic fatty liver disease (NAFLD) framework to the affirmative M...
שמור ב:
| Principais autores: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2026-05-01
|
| סדרה: | Gastroenterology Insights |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/2036-7422/17/2/33 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
